Trade Summary

2 months ago, Elms Steve, serving as Dir at Adma Biologics, Inc. (ADMA), purchased 14,000 shares at $15.53 per share, for a total transaction value of $217,420.00. Following this transaction, Elms Steve now holds 2,143,750 shares of ADMA.

This purchase represents a 1.00% increase in Elms Steve's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, March 5, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 9, 2026, 4 days after the trade was made.

Adma Biologics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.